Jagsonpal Pharmaceuticals Ltd
Key Event: Acquisition Update
The disclosure provides an update on a proposed acquisition previously communicated to the exchanges via a letter dated June 29, 2026. The company has completed a significant portion of its proposed acquisition of an 85% equity stake in Aequitas Healthcare Private Limited ("Aequitas").
Key Quantitative Figures
- The company has acquired a 69.77% stake in Aequitas Healthcare Private Limited.
Transaction Impact
As a consequence of this acquisition, Aequitas Healthcare Private Limited has become a subsidiary of Jagsonpal Pharmaceuticals Limited.
Parties Involved
- Acquirer: Jagsonpal Pharmaceuticals Limited
- Target: Aequitas Healthcare Private Limited